GlobeImmune raises $17.25 million in IPO
Last Updated: 17:52 July 8, 2014
The Louisville-based biopharmaceutical company sold 1.725 million shares of its common stock for $10 each, including 225,000 shares sold pursuant to the exercise of the underwriter's overallotment option.
The gross proceeds amount is prior to the deduction of underwriting discounts and commissions and other offering expenses.
GlobeImmune shares began trading July 2. The share price closed at $12.89 Tuesday, up 12 percent from the previous day's close.
More breaking news...
PivotDesk launches tool for commercial real estate brokers
Clovis’ senior management will host a conference
Japanese agency becomes partner on Dream Chaser
Forbes: Fort Collins, Greeley, Boulder among best places for business
As part of the agreement, SNC will
Fort Collins ranked fifth, one spot behind Denver, while Greeley was 20th and Boulder 23rd.